TFA
YARW

Tobias Financial Advisors’s Yarrow Bioscience YARW Stock Holding History

Tobias Financial Advisors’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12
Closed -$1.65K – 90
2022
Q4 		$1.65K Buy
+12
New +$2.4K ﹤0.01% 81
2022
Q3 		– Sell
-12
Closed -$4K – 86
2022
Q2 		$4K Hold
12
– – ﹤0.01% 85
2022
Q1 		$7K Buy
+12
New +$7.13K ﹤0.01% 74
2021
Q1 		– Sell
-4
Closed -$23K – 71
2020
Q4 		$23K Hold
4
– – 0.01% 67
2020
Q3 		$24K Buy
+4
New +$23.3K 0.01% 67

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Tobias Financial Advisors's YARW Position: Q1 2023 in Review

Tobias Financial Advisors sold out of Yarrow Bioscience (YARW) in Q1 2023, closing a stake of 12 shares — an estimated $1.65K sold.

Tobias Financial Advisors first reported a position in YARW in Q3 2020 and held it in 5 quarters. The position peaked at $24K in Q3 2020. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Tobias Financial Advisors reported no remaining Yarrow Bioscience position as of Q1 2023 after selling out during the quarter.
  • Tobias Financial Advisors sold 12 Yarrow Bioscience shares in Q1 2023, an estimated $1.65K.
  • Tobias Financial Advisors first reported a position in Yarrow Bioscience in Q3 2020 and held it in 5 quarters.
  • Tobias Financial Advisors's Yarrow Bioscience position peaked at $24K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2023.

Based on Tobias Financial Advisors's 13F filing for Q1 2023, filed 24 Apr 2023.